# Deconstructing Cartilage Mechanotransduction by Piezo Channels

> **NIH NIH R01** · DUKE UNIVERSITY · 2020 · $579,232

## Abstract

Osteoarthritis (OA) is painful and debilitating by affecting the synovial joints, and is found in over 12% of the
total United States population 25-74 years of age. The prevalence of OA increases significantly with age, with
radiographic evidence in over 70% of the population over age 65. In this growing segment of our society, OA is
a significant contributor to disability, frailty and social isolation. Despite the tremendous socioeconomic impact
of OA, there are no disease-modifying therapies available. OA is distinctively characterized by the progressive,
degenerative changes in the morphology, composition, and mechanical properties of articular cartilage.
Mechanotransduction in articular chondrocytes is a key component of disease pathogenesis, given the link
between direct sensing of the cells’ mechanical environment and the resulting metabolic imbalance of cartilage
in OA. We have recently identified the mechanosensitive PIEZO ion channels - in fact a synergy between
PIEZO1 and PIEZO2, both expressed in articular cartilage - to underlie chondrocyte mechanotransduction in
response to injurious mechanical stress.
The overall objective of this study is to define the mechanisms of Piezo-mediated mechanotransduction in
chondrocytes more in-depth so that these insights can be leveraged toward the development of disease-
modifying approaches in joint-loading-induced injuries, including OA. In addition to our recent discovery of
chondrocytic Piezo-mediated mechanotransduction, we found that treatment of chondrocytes with
pathophysiologically-relevant concentrations of IL-1α, a pro-inflammatory cytokine, increased Piezo1 gene
expression, and that increased expression of Piezo1 was also present in osteoarthritic cartilage from aging
pigs and humans. Thus, the Specific Aims of this grant are: (1) to determine the mechanisms of synergistic
functioning of Piezo1/2 in chondrocyte mechanotransduction; (2) to deconstruct Piezo-mediated
mechanotransduction in chondrocytes under inflammatory conditions; (3) to elucidate the role of Piezo-
mediated mechanotransduction in organotypic cartilage explants and in-vivo. Aim 1 will rely on cellular studies.
We will explore synergisms of Piezo1/2 at the levels of electrophysiology, channel trafficking, finite element
modeling, and ultra-structure, the latter also examining human cartilage from OA vs controls. In Aim 2 primary
porcine chondrocytes will be stimulated with IL-1α for deconstruction of Piezo-mediated mechanotransduction.
Aim 3 will rely on porcine osteochondral explants and chondrocyte-specific and inducible Piezo1/2-/- mice which
we have generated. Various modes of mechanical stress will be applied to cells, explants, and animals, and
loss-of-function studies of Piezo-mediated mechanotransduction will be conducted with both mechanistic intent
and translational/therapeutic direction. The proposed Aims will extend our initial discovery with mechanistic in-
depth studies that will increase our understanding o...

## Key facts

- **NIH application ID:** 10058640
- **Project number:** 1R01AR072999-01A1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** Farshid Guilak
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $579,232
- **Award type:** 1
- **Project period:** 2020-08-05 → 2021-04-06

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10058640

## Citation

> US National Institutes of Health, RePORTER application 10058640, Deconstructing Cartilage Mechanotransduction by Piezo Channels (1R01AR072999-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10058640. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*